Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1675 of 3546 entries
View as:

Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.

Phase: N/A Priority: Normal
NCT ID: NCT00750360 Org: User:
Start: 10/03/03 End: 12/28/07 Due: 12/28/08

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00561795 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

3 Month PHI PAD PoM Study

Phase: N/A Priority: Normal
NCT ID: NCT02135848 Org: User:
Start: 10/15/10 End: 11/01/11 Due: 11/01/12

Phase I Study of GSK2982772 in Japanese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03590613 Org: User:
Start: 07/19/18 End: 09/26/18 Due: 09/26/19

A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02491463 Org: User:
Start: 07/23/15 End: 01/26/17 Due: 01/26/18

A Second Study to Determine the Effect of GSK256073A on HVTs

Phase: N/A Priority: Normal
NCT ID: NCT00551694 Org: User:
Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Phase: N/A Priority: Normal
NCT ID: NCT00955682 Org: User:
Start: 08/25/09 End: 09/10/12 Due: 09/10/13

A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01277666 Org: User:
Start: 12/20/10 End: 07/11/13 Due: 07/11/14

Bioequivalence and Food Effect Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00495274 Org: User:
Start: 07/02/07 End: 09/26/07 Due: 09/26/08

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02195349 Org: User:
Start: 07/30/14 End: 03/07/18 Due: 03/07/19

Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02613910 Org: User:
Start: 12/23/15 End: 03/23/16 Due: 03/23/17

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03266159 Org: User:
Start: 11/27/17 End: 08/19/20 Due: 08/19/21

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00115622 Org: User:
Start: 12/31/04 End: 01/31/05 Due: 01/31/06

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Phase: N/A Priority: Normal
NCT ID: NCT01682876 Org: User:
Start: 10/07/12 End: 05/30/14 Due: 05/30/15

GSK1349572 Drug Interaction Study With Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00774735 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study

Phase: N/A Priority: Normal
NCT ID: NCT01110200 Org: User:
Start: 04/30/10 End: 05/08/12 Due: 05/08/13

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

Phase: N/A Priority: Normal
NCT ID: NCT01154166 Org: User:
Start: 02/15/10 End: 09/29/11 Due: 09/29/12

Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02880852 Org: User:
Start: 01/23/17 End: 09/08/17 Due: 09/08/18

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00684671 Org: User:
Start: 05/26/08 End: 11/03/08 Due: 11/03/09

A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Phase: N/A Priority: Normal
NCT ID: NCT02956837 Org: User:
Start: 11/10/16 End: 02/05/18 Due: 02/05/19

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)

Phase: N/A Priority: Normal
NCT ID: NCT03029208 Org: User:
Start: 05/11/17 End: 09/24/20 Due: 09/24/21

Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children

Phase: N/A Priority: Normal
NCT ID: NCT02416245 Org: User:
Start: 07/31/14 End: 03/31/15 Due: 03/31/16

Survey on the Pharmacy Follow-up of Alli Purchasers

Phase: N/A Priority: Normal
NCT ID: NCT01387243 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01346852 Org: User:
Start: 07/31/09 End: 04/30/10 Due: 04/30/11

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00861744 Org: User:
Start: 06/03/09 End: 06/18/12 Due: 06/18/13